<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://scholar.gist.ac.kr/handle/local/7980">
    <title>Repository Collection:</title>
    <link>https://scholar.gist.ac.kr/handle/local/7980</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://scholar.gist.ac.kr/handle/local/31973" />
        <rdf:li rdf:resource="https://scholar.gist.ac.kr/handle/local/19818" />
        <rdf:li rdf:resource="https://scholar.gist.ac.kr/handle/local/19833" />
        <rdf:li rdf:resource="https://scholar.gist.ac.kr/handle/local/19832" />
      </rdf:Seq>
    </items>
    <dc:date>2025-12-08T05:05:37Z</dc:date>
  </channel>
  <item rdf:about="https://scholar.gist.ac.kr/handle/local/31973">
    <title>Toward Early Alzheimer’s Disease Diagnosis:  Development of an Integrated EEG-fNIRS System and  EEG-Based Evaluation of P300 Latency as a  Physiological Marker</title>
    <link>https://scholar.gist.ac.kr/handle/local/31973</link>
    <description>Title: Toward Early Alzheimer’s Disease Diagnosis:  Development of an Integrated EEG-fNIRS System and  EEG-Based Evaluation of P300 Latency as a  Physiological Marker
Author(s): Manal Mustafa Mohamedali Mohamed
Abstract: The primary focus of this dissertation is the neurophysiological analysis of event-related potentials (ERPs), with particular emphasis on P300 latency, to identify reliable biomarkers for the early detection of Alzheimer’s Disease (AD). By investigating electrophysiological signals associated with early cognitive decline, this research aims to distinguish the preclinical stages of AD. Based on the analytical requirements and insights derived from this investigation, we subsequently developed and validated a novel multimodal brain monitoring system that integrates electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) to enhance detection sensitivity and spatial resolution.
Chapter 1 presents a comprehensive overview of Alzheimer’s Disease (AD), beginning with the increasing global burden of the disease and the pressing need for early detection during its asymptomatic and prodromal AD stages. It outlines the clinical progression of AD, from healthy aging through the preclinical and mild cognitive impairment phases to overt dementia, highlighting key pathological hallmarks such as amyloid-beta accumulation, tau neurofibrillary tangles, neuroinflammation, synaptic dysfunction, and structural and functional brain alterations. The chapter critically evaluates existing diagnostic approaches, including the AT(N) framework and other biomarker-based criteria, while emphasizing the limitations of conventional neuroimaging and cerebrospinal fluid analyses in early-stage detection due to their invasiveness, cost, and limited accessibility. As a response, it introduces electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) as non-invasive, cost-effective alternatives capable of capturing complementary neurophysiological information. Special focus is placed on the event-related P300 component, elicited via the oddball paradigm, due to its sensitivity to attention and working memory processes that are often compromised early in the AD continuum. This rationale supports the need for integrated, time-efficient, and scalable brain monitoring tools that can serve as early biomarkers and enhance both clinical screening and public health intervention strategies.
Chapter 2 investigates P300 ERP indices—specifically peak latency and amplitude—as potential biomarkers for distinguishing between healthy controls (HC), individuals with asymptomatic AD (AAD), and those with prodromal AD (PAD). EEG data were collected during a visual oddball task from 79 participants. Findings reveal that P300 peak latency, but not amplitude, significantly differentiates PAD from both AAD and HC. Moreover, P300 latency correlates significantly with memory domain scores, reinforcing its role as a neurophysiological marker of early cognitive impairment. This chapter focuses exclusively on EEG-based analysis, as fNIRS-related investigations are being pursued by other research groups. The integration of EEG and fNIRS data remains a direction for future work.
Chapter 3 extends the investigation to a larger cohort of 117 participants and explores the topographical distribution of P300 latency across the left, middle, and right brain regions. Results show that P300 latency from the left hemisphere distinguishes HC from AAD, while latency from all regions separates HC from PAD. Receiver Operating Characteristic (ROC) analyses confirm the diagnostic potential of P300 latency with favorable sensitivity and specificity, particularly in the left and middle regions. However, differentiation between AAD and PAD remains limited, suggesting a need for complementary multimodal or longitudinal approaches.
Chapter 4 details the design and implementation of a portable, low-cost EEG/fNIRS brain function monitoring system. The system incorporates the ADS1298IPAG analog front-end and a Teensy 3.2 microcontroller, allowing for simultaneous acquisition of two-channel EEG and six-channel fNIRS signals. The system’s hardware, software, and graphical user interface (GUI) are described, and performance validation confirms its suitability for real-time, dual-modal brain monitoring.
Chapter 5 concludes by summarizing the successful development of a low-cost, integrated EEG/fNIRS system and the identification of P300 latency as a viable physiological marker for early AD screening. This dissertation contributes a scalable, accessible neurodiagnostic platform that bridges engineering innovation with clinical neuroscience. Future directions include system miniaturization, the integration of EEG and fNIRS data for Alzheimer's Disease classification, the incorporation of machine learning models to enhance diagnostic accuracy, and validation across larger and more diverse populations.
Together, this work advances biomedical engineering by delivering a novel brain monitoring solution that is both physiologically informative and practically applicable for early Alzheimer’s Disease detection.</description>
    <dc:date>2024-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="https://scholar.gist.ac.kr/handle/local/19818">
    <title>Therapeutic Effects of Auditory Stimulation at 40 Hz on Sleep Disturbances in an Alzheimer`s Disease Mouse Model: Focusing on the Role of Astrocytes</title>
    <link>https://scholar.gist.ac.kr/handle/local/19818</link>
    <description>Title: Therapeutic Effects of Auditory Stimulation at 40 Hz on Sleep Disturbances in an Alzheimer`s Disease Mouse Model: Focusing on the Role of Astrocytes
Author(s): 박민철
Abstract: The sensory stimulation at 40 Hz showed therapeutic impacts on Alzheimer`s disease (AD). Previous studies reported that amyloid-beta (Aβ) accumulation and sleep disturbances in AD have positive feedback loop and impaired Ca2+ influx and volume transient in astrocytes. However, the role of astrocytes to sleep disturbances remains unknown. We hypothesized that 40-Hz auditory stimulation could ameliorate sleep disturbances by enhancing the astrocytic Ca2+ influx. We used 6-month-old 5xFAD as Alzheimer`s disease model. Two-hour daily 40-Hz auditory stimulation were applied for two-weeks. We recorded the 24-hour electroencephalographic (EEG) for sleep-wake analysis at pre- and post-stimulation day. Reactive astrocytes and GABA were measured using immunohistochemistry. Patch clamping recordings measured the tonic GABA currents of nNOS neurons. Using GCaMP6f and intrinsic optical singals were measured astrocytic Ca2+ and volume swelling. qRT-PCR measured the transcriptional levels. Our studiy demonstrated that repeated auditory steady state responses (rASSR) at 40 Hz mitigated Aβ pathology and sleep disturbances. We observed that astrocytic γ-aminobutyric acid (GABA) reduced inhibition on neuronal nitric oxide synthase (nNOS)-containing neurons, sleep-promoting cortical neurons, by rASSR. Additionally, rASSR enhanced neuronal activity-induced transient volume and Ca2+ influx in astrocytes, which subsequently decreased monoamine oxidase B (MAO-B) and increased nuclear factor erythroid 2-related factor 2 (Nrf2). Finally, optogenetic boosting of astrocytic Ca2+ influx using MonSTIM1 mimicked the therapeutic effects of the rASSR at 40 Hz. Our findings suggest that 40-Hz rASSR ameliorates Aβ pathology and sleep disturbances by neuron-astrocyte interaction.</description>
    <dc:date>2024-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="https://scholar.gist.ac.kr/handle/local/19833">
    <title>The roles of nutritional factors and gut-brain axis in the pathogenesis of psychiatric disorders: Implications on Alzheimer’s disease and ADHD</title>
    <link>https://scholar.gist.ac.kr/handle/local/19833</link>
    <description>Title: The roles of nutritional factors and gut-brain axis in the pathogenesis of psychiatric disorders: Implications on Alzheimer’s disease and ADHD
Author(s): Jiseung Kang
Abstract: This dissertation aims to investigate the potential links between metabolic dysregulation,
the gut-brain axis, and neurodegenerative diseases. It comprises three chapters that focus on
exploring the effects of vitamin D deficiency on Alzheimer's disease (AD) amyloidopathy and
gliopathy, examining the impact of a high-fat diet (HFD) on dopaminergic dysregulation, REM
sleep fragmentation, and attention-deficit hyperactivity disorder (ADHD)-like behaviors and the
causal relationship between slow gut transition and AD pathology.
In Chapter 1, I explored the role of vitamin D in AD pathology. Lower serum vitamin
D levels have been associated with higher AD risk, but the underlying mechanisms remain
unclear. My findings suggested that vitamin D plays a crucial role in modifying the course of AD
by regulating amyloid pathology. Vitamin D deficiency led to an increase in brain amyloid-beta
(Aβ) levels and changes in gene expression, while vitamin D supplementation reduced Aβ levels
and improved memory function. Furthermore, I found that vitamin D deficiency exacerbated Aβ
pathology and increased GABA-positive reactive astrocytes, whereas vitamin D supplementation
ameliorated these effects. These results suggested that vitamin D could be a potential preventive
and therapeutic nutritional approach for AD.
In Chapter 2, I examined the effects of a high-fat diet (HFD) on dopaminergic
dysregulation and behavioral deficits in male mice. The HFD group showed decreased
ii
wakefulness, fragmented REM sleep, ADHD-like behaviors, including anxiety, anhedonia,
hyperactive-like behaviors, and impaired visuospatial memory. Additionally, the HFD group had
decreased mRNA levels of dopamine-related genes in the brain regions of dopaminergic reward
circuits. My findings suggest that HFD-induced behavioral deficits and disturbed REM sleep are
associated with dysregulation of the dopaminergic system.
Chapter 3 focused on the relationship between slow gut transition and AD pathology.
Epidemiological studies have suggested a high prevalence of constipation in neurodegenerative
disorders, including AD. My findings supported the notion that slow gut transition leads to a
leaky gut, resulting in systemic inflammation and accelerated amyloidopathy. Importantly, this
study also found that loperamide-induced slow gut transition caused memory impairment in wildtype
mice. The study provided critical insights into the potential role of maintaining gut health in
AD prevention and treatment.
This dissertation investigated the links between metabolic dysregulation, the gut-brain
axis, and neurodegenerative diseases, focusing on the effects of vitamin D deficiency, high-fat
diets, and slow gut transition on various pathological aspects. The findings suggest that vitamin
D plays a crucial role in modifying AD progression by regulating amyloid pathology and
gliopathy, while high-fat diets lead to dopaminergic dysregulation, disturbed REM sleep, and
ADHD-like behaviors. Additionally, the slow gut transition was found to exacerbate AD
pathology through systemic inflammation and accelerated amyloidopathy. These results
highlight the potential of nutritional interventions and maintaining gut health as preventive and
therapeutic approaches for AD and other neurodegenerative disorders.</description>
    <dc:date>2022-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="https://scholar.gist.ac.kr/handle/local/19832">
    <title>The role of TonEBP on the regulation of microtubule dynamics and ciliogenesis.</title>
    <link>https://scholar.gist.ac.kr/handle/local/19832</link>
    <description>Title: The role of TonEBP on the regulation of microtubule dynamics and ciliogenesis.
Author(s): Chinbold, Batchingis
Abstract: ABSTRACT

Microtubules are fundamental components of the cytoskeleton essential for maintaining cellular architecture, facilitating intracellular transport, and enabling cell division. Additionally, microtubules are the core structural components of primary cilia, which are slender, microtubule-based organelles that extend from the cell surface. Primary cilia act as essential sensory antennae, detecting and transducing extracellular signals that regulate a myriad of cellular processes, including development, differentiation, and tissue homeostasis. TonEBP is a transcription factor canonically associated with cellular response to hypertonic stress, during which microtubule cytoskeleton and primary cilia play contributing roles to this adaptation. However, a direct link among TonEBP, microtubule cytoskeleton and primary cilia is unclear. This study introduces a novel role of TonEBP as a regulator of microtubule dynamics and ciliogenesis. Initial findings reveal that TonEBP is enriched at the centrosome – the main microtubule organizing center. Interestingly, the stability of TonEBP is dependent on intact microtubule network, disruption of which causes rapid degradation of TonEBP. This has shown to be necessary for efficient microtubule regrowth, as presence of TonEBP inhibits microtubule nucleation at the centrosome. Moreover, TonEBP is a negative regulator of ciliogenesis. Depletion of TonEBP facilitates the formation of primary cilia, whereas its overexpression results in fewer ciliated cells. Furthermore, TonEBP modulates the expression and activity of aurora kinase A, a key negative regulator of ciliogenesis. Finally, TonEBP regulates the integrity of centriolar satellites, which are essential for primary cilia formation. Collectively, this dissertation proposes previously uncharacterized regulation of TonEBP on microtubule dynamics and ciliogenesis, revealing a novel physiological function of TonEBP.</description>
    <dc:date>2024-12-31T15:00:00Z</dc:date>
  </item>
</rdf:RDF>

